Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1107 | 990 | 1228 | 1205 | 1419 | 1997 |
Fund Return | 10.67% | -0.98% | 22.81% | 6.41% | 7.25% | 7.16% |
Place in category | 251 | 349 | 231 | 134 | 618 | 166 |
% in Category | 10 | 16 | 9 | 7 | 39 | 13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Seligson Co Global Top 25 Brands Fu | 713.69M | 8.06 | 5.53 | 11.68 | ||
Seligson & Co Global Top 25 Brands | 713.69M | 8.06 | 5.52 | 11.64 | ||
Seligson North American B | 534.76M | 26.69 | 13.09 | 14.29 | ||
Seligson & Co North American A | 534.76M | 26.70 | 13.09 | 14.31 | ||
FI4000283031 | 385.74M | 25.38 | 13.01 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
OP-Eurooppa Indeksi B | 1.23B | 12.54 | 8.30 | 6.74 | ||
OP-Eurooppa Indeksi A | 1.23B | 12.54 | 8.30 | 6.74 | ||
OP-Eurooppa Indeksi II A | 1.23B | 10.54 | 8.82 | 6.80 | ||
OP-Eurooppa Indeksi II B | 1.23B | 10.54 | 8.81 | 6.80 | ||
Nordea Eurooppa T EUR | 614M | 5.42 | 3.07 | 7.11 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ASML Holding | NL0010273215 | 5.98 | 627.70 | -1.92% | |
SAP | DE0007164600 | 5.28 | 220.150 | -1.37% | |
AstraZeneca | GB0009895292 | 4.87 | 10,532.0 | +0.38% | |
Roche Holding Participation | CH0012032048 | 4.78 | 252.50 | +0.44% | |
Novartis | CH0012005267 | 4.67 | 92.75 | +0.89% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Neutral | Buy |
Technical Indicators | Sell | Strong Sell | Strong Buy |
Summary | Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review